Cases where imaging suggests centrally located tumours near nipple (concerns NSM): Radiotherapy approach in patients with macrometastatic SLN that did not undergo ALND
In a patient with a tumour below 5 cm and 1-2 positive SLNs that has undergone a breast conserving procedure and is scheduled for whole breast irradiation («Z11 criteria»):
This patient can be treated with whole breast irradiation without 3rd/additional axillary field/high tangents.
41,70%
Additional axillary radiation should be added in all cases.
29,20%
Additional axillary radiation should be added in cases of aggressive histologies/subtypes such as TNBC. 25% Abstain 4,20%
Surgery of the Axilla: postmastectomy
Based on e.g. the AMAROS trial and other data sets, the preferred approach for women with T1-2 cancers undergoing mastectomy and SLN mapping with macro-metastases in 1-2 sentinel nodes should be (assuming standard systemic adjuvant therapy): No additional therapy to the axilla 12,50% The 21-gene recurrence score, if available, is widely used to assist adjuvant chemotherapy decisions, and that based on TAILORx, women with node-negative cancers and recurrence scores < 25 do not need chemotherapy. In patients with known BRCA mutation: 
